FerroptoCure Inc.
FerroptoCure is a clinical stage company developing novel new ferroptosis inducing anti-cancer therapy. FerroptoCure has completed a Phase1a trial of the lead project in Japan and seeking partners to out-license and investors.
)
January 11-15, 2027 | San Francisco
January 11-15, 2027 | San Francisco
)
)
January 11-15, 2027 | San Francisco
){kind=logo}
)